Beluga Health Review
Best for: Brands launching DTC GLP-1 telehealth; less direct for individual shoppers
Beluga Health is a nationwide white-label telehealth medical group led by Dr. Jonah Mink that powers other companies' direct-to-consumer health brands rather than selling to consumers itself. It provides licensed-provider care and supports GLP-1 weight-loss offerings, with compounded semaglutide and tirzepatide titrated by clinicians and dispensed through independent pharmacies such as CareGLP and Belmar. As a B2B infrastructure provider it has no public consumer price, and it has been cited among nationwide groups linked to FDA telehealth GLP-1 marketing scrutiny.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Beluga Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Beluga Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Supports GLP-1 care with compounded semaglutide and tirzepatide
- •Board-certified providers and a 50-state medical infrastructure
- •LegitScript certified with SOC 2 and ISO 27001 security
- •Pharmacies follow FDA/USP standards with third-party batch testing
- •Powers many DTC brands as a turnkey telehealth backbone
✗ Cons
- •White-label B2B group, not a direct consumer-facing service
- •Offers compounded, not FDA-approved branded, GLP-1s
- •No public consumer pricing for the GLP-1 offering
- •Cited among nationwide groups tied to FDA telehealth GLP-1 scrutiny
- •Care quality varies by the consumer brand using the platform
Ready to start with Beluga Health?
See current pricing and start your free consultation.
Sources & methodology
Our Beluga Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Beluga Health
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Beluga Health?
See current pricing and start your free consultation.